Literature DB >> 18000842

Improving sequence variant descriptions in mutation databases and literature using the Mutalyzer sequence variation nomenclature checker.

Martin Wildeman1, Ernest van Ophuizen, Johan T den Dunnen, Peter E M Taschner.   

Abstract

Unambiguous and correct sequence variant descriptions are of utmost importance, not in the least since mistakes and uncertainties may lead to undesired errors in clinical diagnosis. We developed the Mutation Analyzer (Mutalyzer) sequence variation nomenclature checker (www.lovd.nl/mutalyzer; last accessed 13 September 2007) for automated analysis and correction of sequence variant descriptions using reference sequences from any organism. Mutalyzer handles most variation types: substitution, deletion, duplication, insertion, indel, and splice-site changes following current recommendations of the Human Genome Variation Society (HGVS). Input is a GenBank accession number or an uploaded reference sequence file in GenBank format with user-modified annotation, an HGNC gene symbol, and the variant (single or in a batch file). Mutalyzer generates variant descriptions at DNA level, the level of all annotated transcripts and the deduced outcome at protein level. To validate Mutalyzer's performance and to investigate the sequence variant description quality in locus-specific mutation databases (LSDBs), more than 11,000 variants in the PAH, BIC BRCA2, and HbVar databases were analyzed, showing that 87%, 25%, and 38%, respectively, were error-free and following the recommendations. Low recognition rates in BIC and HbVar (38% and 51%, respectively) were due to lack of a well-annotated genomic reference sequence (HbVar) or noncompliance to the guidelines (BRCA2). Provided with well-annotated genomic reference sequences, Mutalyzer is very effective for the curation of newly discovered sequence variation descriptions and existing LSDB data. Mutalyzer will be linked to the Leiden Open source Variation Database (LOVD) (www.LOVD.nl; last accessed 13 September 2007) and is the first module of a sequence variant effect prediction package. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18000842     DOI: 10.1002/humu.20654

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  179 in total

1.  Identification of Lynch syndrome mutations in the MLH1-PMS2 interface that disturb dimerization and mismatch repair.

Authors:  Jan Kosinski; Inga Hinrichsen; Janusz M Bujnicki; Peter Friedhoff; Guido Plotz
Journal:  Hum Mutat       Date:  2010-08       Impact factor: 4.878

2.  Novel germline PALB2 truncating mutations in African American breast cancer patients.

Authors:  Yonglan Zheng; Jing Zhang; Qun Niu; Dezheng Huo; Olufunmilayo I Olopade
Journal:  Cancer       Date:  2011-08-26       Impact factor: 6.860

Review 3.  Hematologically important mutations: leukocyte adhesion deficiency (first update).

Authors:  Edith van de Vijver; Anne Maddalena; Özden Sanal; Steven M Holland; Gulbu Uzel; Manisha Madkaikar; Martin de Boer; Karin van Leeuwen; M Yavuz Köker; Nima Parvaneh; Alain Fischer; S K Alex Law; Nigel Klein; F Ilhan Tezcan; Ekrem Unal; Turkan Patiroglu; Bernd H Belohradsky; Klaus Schwartz; Raz Somech; Taco W Kuijpers; Dirk Roos
Journal:  Blood Cells Mol Dis       Date:  2011-11-30       Impact factor: 3.039

4.  Reporting of Genetic Variants by Diagnostic Laboratories and other Centres.

Authors:  John-Paul Plazzer; Johan T den Dunnen; Timothy Smith; Finlay Macrae; Richard G Cotton
Journal:  Clin Biochem Rev       Date:  2012-02

5.  Characterization of novel SLC6A8 variants with the use of splice-site analysis tools and implementation of a newly developed LOVD database.

Authors:  Ofir T Betsalel; Efraim H Rosenberg; Ligia S Almeida; Tjitske Kleefstra; Charles E Schwartz; Vassili Valayannopoulos; Omar Abdul-Rahman; Nicola Poplawski; Laura Vilarinho; Philipp Wolf; Johan T den Dunnen; Cornelis Jakobs; Gajja S Salomons
Journal:  Eur J Hum Genet       Date:  2010-08-18       Impact factor: 4.246

Review 6.  Hematologically important mutations: X-linked chronic granulomatous disease (third update).

Authors:  Dirk Roos; Douglas B Kuhns; Anne Maddalena; Joachim Roesler; Juan Alvaro Lopez; Tadashi Ariga; Tadej Avcin; Martin de Boer; Jacinta Bustamante; Antonio Condino-Neto; Gigliola Di Matteo; Jianxin He; Harry R Hill; Steven M Holland; Caroline Kannengiesser; M Yavuz Köker; Irina Kondratenko; Karin van Leeuwen; Harry L Malech; László Marodi; Hiroyuki Nunoi; Marie-José Stasia; Anna Maria Ventura; Carl T Witwer; Baruch Wolach; John I Gallin
Journal:  Blood Cells Mol Dis       Date:  2010-08-21       Impact factor: 3.039

Review 7.  Human genotype-phenotype databases: aims, challenges and opportunities.

Authors:  Anthony J Brookes; Peter N Robinson
Journal:  Nat Rev Genet       Date:  2015-11-10       Impact factor: 53.242

8.  Locus-specific databases and recommendations to strengthen their contribution to the classification of variants in cancer susceptibility genes.

Authors:  Marc S Greenblatt; Lawrence C Brody; William D Foulkes; Maurizio Genuardi; Robert M W Hofstra; Magali Olivier; Sharon E Plon; Rolf H Sijmons; Olga Sinilnikova; Amanda B Spurdle
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

9.  CC2D2A mutations in Meckel and Joubert syndromes indicate a genotype-phenotype correlation.

Authors:  Soumaya Mougou-Zerelli; Sophie Thomas; Emmanuelle Szenker; Sophie Audollent; Nadia Elkhartoufi; Candice Babarit; Stéphane Romano; Rémi Salomon; Jeanne Amiel; Chantal Esculpavit; Marie Gonzales; Estelle Escudier; Bruno Leheup; Philippe Loget; Sylvie Odent; Joëlle Roume; Marion Gérard; Anne-Lise Delezoide; Suonavy Khung; Sophie Patrier; Marie-Pierre Cordier; Raymonde Bouvier; Jéléna Martinovic; Marie-Claire Gubler; Nathalie Boddaert; Arnold Munnich; Férechté Encha-Razavi; Enza Maria Valente; Ali Saad; Sophie Saunier; Michel Vekemans; Tania Attié-Bitach
Journal:  Hum Mutat       Date:  2009-11       Impact factor: 4.878

10.  The phenotypic spectrum of ZIC3 mutations includes isolated d-transposition of the great arteries and double outlet right ventricle.

Authors:  Lisa C A D'Alessandro; Brande C Latney; Prasuna C Paluru; Elizabeth Goldmuntz
Journal:  Am J Med Genet A       Date:  2013-02-20       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.